v3.26.3
SEGMENT INFORMATION - Segment Revenues and Profit (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Segment reporting information        
Revenues $ 1,375 $ 1,281 $ 4,013 $ 3,696
Selling, general and administrative 556 528 1,688 1,670
Research and development 91 95 306 277
Operating income 155 95 271 1
Amortization of intangible assets (57) (68) (171) (202)
Other (expense) income, net (30) 15 (81) (29)
Interest income 2 3 10 9
Interest expense (95) (101) (285) (323)
Gain (loss) on extinguishment of debt 0 3 (1) (6)
Foreign exchange and other (4) (3) (12) (11)
Income (loss) before provision for income taxes 58 (3) (17) (330)
Vision Care        
Segment reporting information        
Revenues 774 736 2,269 2,145
Pharmaceuticals        
Segment reporting information        
Revenues 367 330 1,026 906
Surgical        
Segment reporting information        
Revenues 234 215 718 645
Product sales        
Segment reporting information        
Revenues 1,371 1,277 3,999 3,682
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues 485 509 1,494 1,513
Other revenues        
Segment reporting information        
Revenues 4 4 14 14
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues 1 1 2 4
Operating Segment        
Segment reporting information        
Revenues 1,375 1,281 4,013 3,696
Operating income 410 301 1,022 729
Operating Segment | Vision Care        
Segment reporting information        
Revenues 774 736 2,269 2,145
Selling, general and administrative 240 225 715 689
Research and development 9 15 36 34
Operating income 244 217 675 602
Operating Segment | Pharmaceuticals        
Segment reporting information        
Revenues 367 330 1,026 906
Selling, general and administrative 127 132 414 439
Research and development 17 15 66 36
Operating income 134 76 289 124
Operating Segment | Surgical        
Segment reporting information        
Revenues 234 215 718 645
Selling, general and administrative 77 72 230 218
Research and development 9 11 34 34
Operating income 32 8 58 3
Operating Segment | Product sales        
Segment reporting information        
Revenues 1,371 1,277 3,999 3,682
Operating Segment | Product sales | Vision Care        
Segment reporting information        
Revenues 773 734 2,262 2,139
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues 281 279 843 820
Operating Segment | Product sales | Pharmaceuticals        
Segment reporting information        
Revenues 366 329 1,024 902
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues 88 106 255 303
Operating Segment | Product sales | Surgical        
Segment reporting information        
Revenues 232 214 713 641
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues 116 124 396 390
Operating Segment | Other revenues        
Segment reporting information        
Revenues 4 4 14 14
Operating Segment | Other revenues | Vision Care        
Segment reporting information        
Revenues 1 2 7 6
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues 0 0 0 0
Operating Segment | Other revenues | Pharmaceuticals        
Segment reporting information        
Revenues 1 1 2 4
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues 1 1 2 4
Operating Segment | Other revenues | Surgical        
Segment reporting information        
Revenues 2 1 5 4
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues 0 0 0 0
Corporate        
Segment reporting information        
Operating income $ (168) $ (153) $ (499) $ (497)